|
CO4600681A1
(es)
|
1996-02-24 |
1998-05-08 |
Boehringer Ingelheim Pharma |
Composicion farmaceutica para la modulacion inmunitaria
|
|
DE19803453A1
(de)
|
1998-01-30 |
1999-08-12 |
Boehringer Ingelheim Int |
Vakzine
|
|
CA2321596C
(en)
*
|
1998-02-25 |
2012-05-29 |
Gregory M. Glenn |
Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by adp-ribosylating exotoxin
|
|
ES2283053T3
(es)
*
|
1998-04-20 |
2007-10-16 |
Torrey Pines Institute For Molecular Studies |
Inmunoestimulacion topica para inducir la migracion celular de langerhans.
|
|
WO2000048630A1
(en)
*
|
1999-02-17 |
2000-08-24 |
Csl Limited |
Immunogenic complexes and methods relating thereto
|
|
DE19909503A1
(de)
*
|
1999-03-04 |
2000-09-07 |
Boehringer Ingelheim Int |
Tumorassoziiertes Antigen
|
|
US6809179B1
(en)
|
1999-08-04 |
2004-10-26 |
Boehringer Ingelheim International Gmbh |
Tumor-associated antigen (R11)
|
|
WO2005004910A2
(en)
|
2003-07-11 |
2005-01-20 |
Intercell Ag |
Hcv vaccines
|
|
AT408721B
(de)
|
1999-10-01 |
2002-02-25 |
Cistem Biotechnologies Gmbh |
Pharmazeutische zusammensetzung enthaltend ein antigen
|
|
AT409085B
(de)
*
|
2000-01-28 |
2002-05-27 |
Cistem Biotechnologies Gmbh |
Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
|
|
US20020009491A1
(en)
*
|
2000-02-14 |
2002-01-24 |
Rothbard Jonathan B. |
Compositions and methods for enhancing drug delivery across biological membranes and tissues
|
|
AT409762B
(de)
*
|
2000-04-13 |
2002-11-25 |
Cistem Biotechnologies Gmbh |
Verfahren zur identifizierung von zytokin sekretierenden zellen
|
|
AT410173B
(de)
|
2000-06-08 |
2003-02-25 |
Cistem Biotechnologies Gmbh |
Antigene zusammensetzung
|
|
KR20020014459A
(ko)
*
|
2000-08-18 |
2002-02-25 |
서진호 |
양이온성 아미노산이 부가된 융합단백질 및 이를 이용한생물공정의 개선방법
|
|
EP1347775B1
(en)
*
|
2001-01-05 |
2016-11-30 |
Valneva Austria GmbH |
Uses for polycationic compounds as vaccine adjuvants
|
|
WO2002053185A2
(en)
*
|
2001-01-05 |
2002-07-11 |
Intercell Ag |
Anti-inflammatory use of polycationic compounds
|
|
US7244438B2
(en)
|
2001-01-05 |
2007-07-17 |
Intercell Ag |
Uses for polycationic compounds
|
|
AT410798B
(de)
|
2001-01-26 |
2003-07-25 |
Cistem Biotechnologies Gmbh |
Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
|
|
FR2824326B1
(fr)
*
|
2001-05-04 |
2004-03-19 |
Commissariat Energie Atomique |
Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications
|
|
JP2005519035A
(ja)
*
|
2001-12-07 |
2005-06-30 |
インターツェル・アクチェンゲゼルシャフト |
免疫促進性オリゴデオキシヌクレオチド
|
|
US20050221350A1
(en)
*
|
2002-05-29 |
2005-10-06 |
Toni Weinschenk |
Method for identifying immunoreactive peptides
|
|
US7528223B2
(en)
|
2002-07-24 |
2009-05-05 |
Intercell Ag |
Antigens encoded by alternative reading frames from pathogenic viruses
|
|
JP2006504687A
(ja)
|
2002-09-13 |
2006-02-09 |
インターツェル・アクチェンゲゼルシャフト |
Ｃ型肝炎ウイルスペプチドの単離方法
|
|
CN102174533A
(zh)
|
2002-10-15 |
2011-09-07 |
英特塞尔股份公司 |
编码b族链球菌粘着因子的核酸、b族链球菌的粘着因子和它们的用途
|
|
EP1601770B1
(en)
|
2003-03-04 |
2009-09-02 |
Intercell AG |
Streptococcus pyogenes antigens
|
|
US7704514B2
(en)
|
2003-03-24 |
2010-04-27 |
Intercell Ag |
Vaccines
|
|
WO2004087746A2
(en)
|
2003-03-31 |
2004-10-14 |
Intercell Ag |
Staphylococcus epidermidis antigens
|
|
CN102174534A
(zh)
|
2003-04-15 |
2011-09-07 |
英特塞尔股份公司 |
肺炎链球菌抗原
|
|
EP1620460A2
(en)
|
2003-05-07 |
2006-02-01 |
Intercell AG |
Streptococcus agalactiae antigens i + ii
|
|
CA2525540A1
(en)
|
2003-05-30 |
2004-12-09 |
Intercell Ag |
Enterococcus antigens
|
|
DE602005004014T2
(de)
|
2004-03-12 |
2008-12-11 |
Intercell Ag |
Verfahren zur solubilisierung von peptid-mischungen
|
|
DE102004038134B4
(de)
|
2004-08-05 |
2013-07-25 |
Johann Wolfgang Goethe-Universität Frankfurt am Main |
Multivalente Chelatoren zum Modifizieren und Organisieren von Zielmolekülen, Verfahren zu ihrer Herstellung sowie ihre Verwendung
|
|
PL1791858T3
(pl)
|
2004-09-24 |
2010-09-30 |
Intercell Ag |
Zmodyfikowane białko kapsydowe VP1 z parwowirusa B19
|
|
WO2006045677A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Intercell Ag |
Hcv vaccines for chronic hcv patients
|
|
US7785612B2
(en)
*
|
2005-04-20 |
2010-08-31 |
Taiho Pharmaceutical Co., Ltd. |
Polyamino acid for use as adjuvant
|
|
EP1887084A1
(en)
|
2006-08-10 |
2008-02-13 |
International Investment and Patents SA |
Plasmids with immunological action
|
|
WO2008031133A2
(en)
|
2006-09-15 |
2008-03-20 |
Intercell Ag |
Borrelia antigens
|
|
JP2008174490A
(ja)
*
|
2007-01-18 |
2008-07-31 |
Nitto Denko Corp |
抗原性ペプチドを主成分とする薬剤
|
|
JP2010532657A
(ja)
|
2007-05-02 |
2010-10-14 |
インターセル アーゲー |
クレブシエラ属の抗原
|
|
KR100748265B1
(ko)
*
|
2007-06-15 |
2007-08-10 |
(주)성문엔지니어링 |
공동주택에 배선된 전선의 합선방지구조
|
|
US20100203075A1
(en)
|
2007-06-18 |
2010-08-12 |
Intercell Ag |
Chlamydia antigens
|
|
PL2173376T3
(pl)
|
2007-08-02 |
2015-08-31 |
Biondvax Pharmaceuticals Ltd |
Multimeryczne wieloepitopowe szczepionki przeciwko grypie
|
|
WO2009120378A2
(en)
*
|
2008-03-27 |
2009-10-01 |
Nestec S.A. |
Methods for increasing absorption of peptides, peptidomimetics, and other gastrointestinal transport protein substrates
|
|
BRPI0922132A2
(pt)
|
2008-12-03 |
2018-10-23 |
Protea Vaccine Tech Ltd |
fragmentos glutamil trna sintetase (gts).
|
|
US8617574B2
(en)
|
2009-02-13 |
2013-12-31 |
Valneva Austria Gmbh |
Nontypable Haemophilus influenzae antigens
|
|
EP2470205A1
(en)
*
|
2009-08-27 |
2012-07-04 |
Novartis AG |
Adjuvant comprising aluminium, oligonucleotide and polycation
|
|
CA2780274C
(en)
|
2009-11-09 |
2018-06-26 |
Spotlight Technology Partners Llc |
Fragmented hydrogels
|
|
CN106913902A
(zh)
|
2009-11-09 |
2017-07-04 |
聚光灯技术合伙有限责任公司 |
多糖基水凝胶
|
|
WO2011067758A2
(en)
|
2009-12-02 |
2011-06-09 |
Protea Vaccine Technologies Ltd. |
Immunogenic fragments and multimers from streptococcus pneumoniae proteins
|
|
WO2011101465A1
(en)
|
2010-02-19 |
2011-08-25 |
Intercell Ag |
Ic31 nanoparticles
|
|
US9303070B2
(en)
|
2011-02-22 |
2016-04-05 |
Biondvax Pharmaceuticals Ltd. |
Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
|
|
RU2478399C2
(ru)
*
|
2011-06-16 |
2013-04-10 |
Государственное научное учреждение Всероссийский научно-исследовательский институт бруцеллеза и туберкулеза животных Российской академии сельскохозяйственных наук (ГНУ ВНИИБТЖ Россельхозакадемии) |
Способ получения специфического иммуномодулятора
|
|
US20140271723A1
(en)
*
|
2013-03-15 |
2014-09-18 |
Saint Louis University |
Adjuvant compositions and methods of using thereof
|
|
US10537626B2
(en)
|
2014-10-07 |
2020-01-21 |
Cytlimic Inc. |
HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell
|
|
SG10201912485PA
(en)
|
2015-05-13 |
2020-02-27 |
Agenus Inc |
Vaccines for treatment and prevention of cancer
|
|
CN108368260B
(zh)
*
|
2015-12-16 |
2020-09-29 |
休伯特保健公司 |
含有角鲨烯的基于两亲性聚氨基酸聚合物的疫苗佐剂组合物
|
|
JP6710004B2
(ja)
*
|
2016-03-15 |
2020-06-17 |
Ｒｅｐｅｒｔｏｉｒｅ Ｇｅｎｅｓｉｓ株式会社 |
免疫療法のためのモニタリングまたは診断ならびに治療剤の設計
|
|
MX2018014602A
(es)
*
|
2016-05-27 |
2019-06-10 |
Etubics Corp |
Composiciones de vacunas neoepitopos y metodos de uso de las mismas.
|
|
CA3039033A1
(en)
|
2016-10-11 |
2018-04-19 |
Cytlimic Inc. |
Medicine
|
|
CN107469067B
(zh)
*
|
2017-09-05 |
2018-06-19 |
浙江大学 |
一种多肽及其改造体在制备免疫调节药物中的应用
|
|
WO2019210055A2
(en)
|
2018-04-26 |
2019-10-31 |
Agenus Inc. |
Heat shock protein-binding peptide compositions and methods of use thereof
|
|
CN110870912A
(zh)
*
|
2018-08-31 |
2020-03-10 |
成都夸常奥普医疗科技有限公司 |
亚甲蓝类染料作为疫苗佐剂的应用、包含该佐剂的疫苗及其应用
|
|
CN110870913A
(zh)
*
|
2018-08-31 |
2020-03-10 |
成都夸常奥普医疗科技有限公司 |
氨基酸类营养素作为疫苗佐剂的应用以及包含氨基酸营养素作为佐剂的疫苗
|
|
CN117860879A
(zh)
*
|
2024-01-10 |
2024-04-12 |
广州医科大学附属肿瘤医院 |
一种纳米疫苗递送系统及其制备方法和应用
|